Date
Thursday, April 2, 2020
8 AM
Sasha is a partner at Greybrook and CEO of Greybrook Securities, where he directs Greybrook’s capital markets activities across the firm’s focus areas. He is an experienced finance professional with over a decade of transaction experience and is a recognized buy-side transactions expert.
Sasha is a member of the board of directors of Greybrook Capital and several of its related entities including Greybrook Realty Partners, Greybrook Securities, Greybrook Health and Greenbrook TMS. Sasha also currently serves on the board of Blu Genes Foundation.
As the co-chair of Greybrook Realty Partners’ Investment Committee, he is responsible for providing oversight and approval of the company’s investments and portfolio acquisitions. Greybrook’s real estate portfolio includes investments in over 70 developments across North America. In aggregate, these assets represent 35 million square feet of residential and commercial density with an estimated completion value of $15 billion.